Patents by Inventor John F. Donovan

John F. Donovan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058316
    Abstract: Described herein is a prodrug of a transient receptor potential vanilloid 1 receptor (TRPV1) agonist for the treatment of pain.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 22, 2024
    Inventors: Sam L. TEICHMAN, Susan KRAMER, John F. DONOVAN
  • Publication number: 20240050421
    Abstract: Provided herein are pharmaceutical formulations comprising a transient receptor potential vanilloid 1 receptor (TRPV1) agonist, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 15, 2024
    Inventors: Susan WOLLOWITZ, John F. DONOVAN
  • Publication number: 20230219901
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: March 16, 2023
    Publication date: July 13, 2023
    Inventors: John F. DONOVAN, Craig HUSFELD
  • Patent number: 11634384
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: April 25, 2023
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: Craig Husfeld, John F. Donovan
  • Publication number: 20220388970
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV 1) activity.
    Type: Application
    Filed: August 3, 2022
    Publication date: December 8, 2022
    Inventors: John F. DONOVAN, Craig HUSFELD
  • Patent number: 11464767
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: October 11, 2022
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: John F. Donovan, Craig Husfeld
  • Publication number: 20220112165
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 14, 2022
    Inventors: John F. DONOVAN, Craig HUSFELD
  • Patent number: 11242325
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: February 8, 2022
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: John F. Donovan, Craig Husfeld
  • Publication number: 20210008050
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: September 24, 2020
    Publication date: January 14, 2021
    Inventors: John F. DONOVAN, Craig HUSFELD
  • Patent number: 10821105
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: November 3, 2020
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: John F. Donovan, Craig Husfeld
  • Publication number: 20200299245
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: June 8, 2020
    Publication date: September 24, 2020
    Inventors: John F. DONOVAN, Craig HUSFELD
  • Patent number: 10717712
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: July 21, 2020
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: John F. Donovan, Craig Husfeld
  • Publication number: 20200031780
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: July 25, 2019
    Publication date: January 30, 2020
    Inventors: John F. DONOVAN, Craig HUSFELD
  • Publication number: 20190284132
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: May 30, 2019
    Publication date: September 19, 2019
    Inventors: Craig HUSFELD, John F. DONOVAN
  • Publication number: 20190216787
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: May 24, 2017
    Publication date: July 18, 2019
    Inventors: John F. DONOVAN, Craig HUSFELD
  • Publication number: 20170260131
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: November 24, 2015
    Publication date: September 14, 2017
    Inventors: Craig HUSFELD, John F. DONOVAN
  • Patent number: 9359316
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: June 18, 2015
    Date of Patent: June 7, 2016
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: Craig Husfeld, John F. Donovan
  • Publication number: 20160145225
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Application
    Filed: June 18, 2015
    Publication date: May 26, 2016
    Inventors: Craig HUSFELD, John F. DONOVAN
  • Patent number: 7140744
    Abstract: A lamp assembly for use in a pressure sensitive paint measuring system, such as for measuring pressure on a test air vehicle using pressure sensitive paint, is constructed and configured to provide (1) exceptional cooling for the various optical elements and the housing, (2) a combination of filters that minimizes heat load on the interference filter, yet provides a high beam intensity at the desired wavelength, (3) a mounting structure for the lamp assembly that allows the lamp assembly to be accurately aimed and positioned with little translation of the output aperture, and (4) easy access to the internal components, including the bulb-reflector assembly and optical elements.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: November 28, 2006
    Assignee: The Boeing Company
    Inventors: David W. Armstrong, John F. Laramie, John F. Donovan, Steven R. Sutton, Robert P. Chase